Ming‐Shiang Wu

Active 1993–2025

Also published as
Ming-Shiang Wu
202
Papers
20,766
Citations
86
h-index
189
i10-index

Citations

Citations per year for Ming‐Shiang Wu1993: 2 citations1995: 1 citations1996: 1 citations1997: 1 citations1998: 6 citations1999: 9 citations2000: 18 citations2001: 11 citations2002: 20 citations2003: 21 citations2004: 24 citations2005: 29 citations2006: 44 citations2007: 47 citations2008: 82 citations2009: 66 citations2010: 88 citations2011: 85 citations2012: 102 citations2013: 123 citations2014: 166 citations2015: 160 citations2016: 172 citations2017: 179 citations2018: 145 citations2019: 621 citations2020: 708 citations2021: 823 citations2022: 777 citations2023: 656 citations2024: 1,051 citations2025: 637 citations2026: 35 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,625 citing papers, 17.4% of this breakdownUnited States: 1,463 citing papers, 15.7% of this breakdownTaiwan: 600 citing papers, 6.4% of this breakdownJapan: 465 citing papers, 5% of this breakdownItaly: 387 citing papers, 4.2% of this breakdownUnited Kingdom: 382 citing papers, 4.1% of this breakdownSouth Korea: 354 citing papers, 3.8% of this breakdownGermany: 309 citing papers, 3.3% of this breakdownFrance: 249 citing papers, 2.7% of this breakdownIndia: 220 citing papers, 2.4% of this breakdownSpain: 218 citing papers, 2.3% of this breakdownAustralia: 211 citing papers, 2.3% of this breakdown
0%17.4%Other 30.4%

Fields

  • Medicine70.5%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Immunology and Microbiology1.9%
  • Neuroscience1.4%
  • Agricultural and Biological Sciences1.1%
  • Computer Science1%
  • Other3.3%

Topics

  • Helicobacter pylori-related gastroenterology studies9.1%
  • Gastric Cancer Management and Outcomes5.2%
  • Gut microbiota and health4.7%
  • Colorectal Cancer Screening and Detection3.4%
  • Liver Disease Diagnosis and Treatment2.7%
  • Clostridium difficile and Clostridium perfringens research2.1%
  • Other72.8%

Coauthors

All papers

Open in search
  1. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2024 cited by 453

  2. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis

    Authors: , , , , , , - Gastroenterology 2016 cited by 1,021

  3. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease

    Authors: , , , , , , , , - Neurology 2022 cited by 240

  4. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 470

  5. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease

    Authors: , , , , , , , , , , - Journal of Neuroinflammation 2019 cited by 469

  6. Pancreatic Cancer Detection on CT Scans with Deep Learning: A Nationwide Population-based Study

    Authors: , , , , , , , , , - Radiology 2022 cited by 166

  7. The interplay between Helicobacter pylori and gastrointestinal microbiota

    Authors: , , , , , - Gut Microbes 2021 cited by 199

  8. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands

    Authors: , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 198

  9. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi‐Chu Chen, Yung-Yueh Chang - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 132

  10. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC–MS

    Authors: , , , , , , , - Journal of Proteome Research 2019 cited by 131

  11. Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation

    Authors: , , , , , , , - The Lancet Digital Health 2020 cited by 213

  12. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 319

  13. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 cited by 208

  14. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass

    Authors: , , , , , , , - Clinical Nutrition 2022 cited by 91

  15. The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management

    Authors: , , , , , - Current Gastroenterology Reports 2019 cited by 213

  16. Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Gut 2018 cited by 161

  17. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ching‐Tai Lee, Wen‐Lun Wang - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 60

  18. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention

    Authors: , , , , , , , - Gut 2012 cited by 344

  19. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 202

  20. Optimization of fecal sample processing for microbiome study — The journey from bathroom to bench

    Authors: , , , , , , - Journal of the Formosan Medical Association 2018 cited by 168

  21. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis

    Authors: , , , , , - BMJ 2015 cited by 170

  22. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation

    Authors: , , , , , , , , , , , , , , , , , , , , - npj Biofilms and Microbiomes 2022 cited by 77

  23. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program

    Authors: , , , , , , , , , , , - Cancer 2015 cited by 277

  24. Screening for gastric cancer in Asia: current evidence and practice

    Authors: , , , , , , , , , , , , , , - The Lancet Oncology 2008 cited by 831